Brca2 Is Very Important Gene Related To The Onset Of Breast Cancer. By: john | - Breast cancer, with its ever increasing number of victims, has become a potential target for the pharmaceutical industries. Fear, pain, stigma and a lot of other such words have associated with breast cancer. The possible cures including chemotherapy with hair loss or surgeries with breast amputation are even horrible to think about. There is undoubtedly a strong need to develop better screening methods for early diagnosis as well as efficacious drugs that can selectively kill the target cells w ... Tags:HTS HTS Assays Rational HTS
Pf-01367338 Inhibited Parp Enzymatic Activity And Par Formation By: john | - PF-01367338 inhibited PARP enzymatic activity and PAR formation in cells with a potency of 5 nM. PF-01367338 inhibited proliferation of MDA-MB-436 cells with an IC50 of 1.2 uM. In addition, PAR formation in tumor-bearing mice was fully inhibited within 30 min at 10 mg/kg. In contrast, iniparib did not inhibit enzymatic activity or PAR formation in vitro. Incubation of iniparib with cell lysates resulted in inhibition of PARP activity with an IC50 of 200 nM, demonstrating that the active nitroso ... Tags:PARP inhibitors
Within any cellular growth process there must be facilities for the replication of DNA, however, this process is not always 100% accurate. In addition mechanisms for the repair of incorrect sequences or the repair of cytotoxic damaged DNA must exist in tandem. PARP is not part of a repair mechanism but it does function as one of the regulatory enzymes controlling the mechanisms that do repair DNA such as the B ... Tags:INHIBITOR
Olaparib Was Well Tolerated When Administered As A Single Agent By: john | - RAD001 (everolimus), an orally bioavailable derivative of rapamycin, is a macrolide antifungal antibiotic that demonstrates potent antiproliferative effects against a variety of mammalian cell types. Specifically, RAD001 inhibits cytokine-driven lymphocyte proliferation , as well as the proliferation of human tumor-derived cells grown either in culture or as tumors in animal models . As a result of these properties, RAD001 is being clinically developed both as an immunosuppressant for prevention ... Tags:INHIBITOR
The Use Of Irreversible Dual-specificity Egfr/erbb2 Inhibitors Has Been Proposed By: john | - Six highly potent and specific PARP inhibitors are currently in clinical development in oncology. BSI201 has entered a phase III trial for triple-negative breast cancer in combination with gemcitabine and carboplatin (G/C). Three agents - olaparib, ABT888, and AG014966 - are in phase II clinical trials as single agents or in combination with chemotherapy. Two PARP inhibitors are in phase I trials: MK4827 and CEP9722. Two additional agents entered clinical development but have not been pursued: G ... Tags:INHIBITOR
Two Good Inhibitors-parp Inhibitor,olaparib,incb018424 By: john | - PARP inhibitor olaparib is able to enhance a pre-existing DNA repair defect in ATM mutant lymphoid tumor cells, leading to the accumulation of unrepaired DNA DSBs and apoptotic-independent cell death, which involved the process of mitotic catastrophe. The growth of ATM mutant Granta-519 tumor cells in a NOD/SCID xenograft model was significantly impaired in the presence of olaparib, both in primary lymphoid organs as well as in subcutaneous tumors. Furthermore, the overall survival of the Granta ... Tags:Olaparib, PARP inhibitor, INCB018424
As many disease conditions are more dependent on PARP enzymes, the targeting of PARP and its inhibition becomes an attractive approach for treating those conditions and cancer is one such example where this approach has been tested successfully. Most of these inhibitors are developed to spare the normal cells which do not often go for DNA replication while killing cancer cells where the deficiency of genes associated with DNA repair enzymes leaves them v ... Tags:Compound Libraries, compound library, High Throughput Screen
It kills 14,000 women in the U.S. each year, and while considered relatively rare has a low rate of survival. It was previously called the Silent Killer because most women are not diagnosed until the cancer has progressed to an advanced stage that no longer responds well to treatment.
Late detection happened primarily because the ovaries are embedded deep in the body, tumors emerging in that organ are difficult to detect, ... Tags:physical examination, pregnancy, Ovarian Cancer
Riding The Mammogram Guideline Roller-coaster By: 4Women | - Have you made your personal peace with the 2009 U.S. Preventative Services Task Force recommendations that annual breast screening should begin at age 50, rather than the previously recommended age of 40? Well, not so fast.
Here comes another set of recommendations, this time brought to you by the American College of Obstetricians and Gynecologists (ACOG). The ACOG is recommending that doctors should offer all women in their 40s the chance to get annual mammograms.
Ovarian Cancer Survival Higher Among Brca Carriers By: 4Women | - Let me start by saying that while Im a supporter of efforts to raise awareness and cure the cancers that kill women, my first choice is prevention. So, when I learned that I was indeed a BRCA2 carrier, I didnt pause long before choosing to undergo both prophylactic mastectomies AND a prophylactic oopherectomy (meaning I had both healthy breasts and healthy ovaries removed). Drastic you say?
ovarian-cancer.jpgAn estimated 15-40 percent of women with a BRCA1 or BRCA2 mutation ... Tags:BRCA2, ovarian cancer, previvor
The study, reported within the journal Cancer, adopted 465 ladies who were examined for strains within the genes BRCA1 and BRCA2 that substantially raise the lifetime perils associated with breast and ovarian cancer.
Women Will Be Able To Know More About Their Breast Cancer Risk By: Anita Brown | - Women carriers of mutated gene BRCA1 can know more about their chances of developing breast cancer in future. This addition to the existing knowledge of breast cancer has come from the study funded by the Breast Cancer Research Foundation and researchers from numerous medical and scientific research centers around the world. The study was published in the medical journal Nature Genetics.
The scientist aimed to identify if any additional genetic variants were responsible for increasi ... Tags:breast cancer, women, brca
Anyone Feeling Pinked Out By: 4Women | - How 'bout those pink-shod NFL players? Ahhhhh, do try the pink lemonade compliments of Delta airlines, and since they do not throw in a pink dinner, be sure to bring your own pink bucket of KFC. Tell me, have you enlisted your kitty in the cause for The Cure with pink Purina cat food?
If you've just arrived and concluded there's a color deficit around here, I assure you, it's temporary. It is Breast Cancer Awareness Month! Time to shop, wear pink denim, shop, invest, shop, run, shop, bi ... Tags:breast cancer awareness month, pink ribbon, the cure
Surviving And Thriving Together! By: 4Women | - What do a vegetarian, a People Magazine designated member of 2009's "Most Beautiful People," first-time pregnant mother, film, Emmy-award winning television, and Broadway star who first hit TV screens at the age of 3 months and ME have in common? Vegetarianism didn't stick with me. People Magazine has yet to discover me. I did pregnancy, three times, and I'm happy to report they're all grown and independent now. I have yet to make my television debut, but Oprah, if you're reading, I'm availa ... Tags:breast cancer, mastectomy, Christina Applegate, BRCA
Risk Factors Of Breast Cancer By: Gina Andrews | - The second deadly disease in women is breast cancer. Over 200,000 women are diagnosed each year in the U.S. Scientists have not discovered why women get breast cancer. However, there are risk factors for breast cancer that has been identified.
One of the risk factors that a woman should be aware of is if there is a history of breast cancer in her family. If one of her close relatives had breast cancer, she would make sure her physician is aware of the history. In some cases, the ... Tags:breast cancer, breast cancer awareness, breast cancer store
Information On Breast Cancer By: mike hayden | - Chances are that you know someone that has been touched by breast cancer and that you want to find a way to get involved. In today's busy world, it is hard to find the time to volunteer to help others so many of us just write a check and hope that the money will help to find a cure for this disease.
Breast cancer has a 10% chance of returning in women who have been successfully treated for the cancer. However, a high percentage of the women who do not have a relapsing breast cance ... Tags:Breast Cancer Information, What is Breast Cancer
Breast Cancer "€" Are Your Genes To Blame? By: Alex White | - For a woman, breast cancer is one of the most dreaded diseases that she can ever develop. The incidence of breast cancer also seems to be quite high, what with almost everyone having someone in the family with breast cancer or at least knowing someone with the disease. Breast cancer is the most common form of cancer in women. It is also the third deadliest cancer in the world, right behind lung cancer and colorectal cancer.
Breast Cancer - Do You Really Need A Mastectomy? - From A Nurse Survivor By: Helen Hecker | - If you've been diagnosed with breast cancer, it may have been suggested you have a single mastectomy in the other breast or a double mastectomy, but is this the best approach? I was diagnosed more than a decade ago with infiltrating intraductal breast cancer and I turned down all conventional breast cancer treatment including chemotherapy, radiation and surgery and chose an alternative route. No single or double mastectomy either. And I'm still in excellent health today.
Life Insurance - Women Furious Over Insurer Gene Testing By: Michael Challiner | - Thousands of women with family histories of breast and ovarian cancer could pay higher insurance premiums or even be denied cover altogether under new proposals from the insurance industry.
The Association of British Insurers (ABI) is expected to lodge an application for permission for its members to ask women whether they have been tested for the BRCA1 and BRCA2 mutations.
The faulty BRCA genes are responsible for about five per cent of the 41,700 new cases of brea ... Tags:life, insurance, cancer, cover
